Meet the Leadership

The leadership of CGON is composed of accomplished experts in global oncology, committed to advancing cancer research and improving patient outcomes. Through innovative strategies and international collaboration, they lead efforts to develop impactful healthcare solutions. Their dedication ensures that CGON remains at the forefront of global cancer care, making a meaningful difference for patients around the world.

  • Chair

    Dr. Danielle Rodin is a radiation oncologist at the Princess Margaret Cancer Centre and an Associate Professor in the Department of Radiation Oncology at the University of Toronto. She is the Director of the Global Cancer Program at Princess Margaret Cancer Centre and previously served on the Board of Directors for the Union for International Cancer Control (UICC).

    Her clinical interests are in breast cancer and hematologic malignancies. She is a health services researcher, with interests in health technology assessment, global health systems, and large database analyses of cost and quality in cancer care. Dr. Rodin received her B.A.(Hons.) from McGill University, her medical degree from the University of Toronto, and her Master of Public Health from Harvard University, and was the 2017-2018 Canadian Harkness Fellow in Health Care Policy and Practice in the Department of Health Policy and Management at the Harvard T. H. Chan School of Public Health.

  • Co-Chair, 2026 Conference

    Prof. Beverley Essue is an Associate Professor of Global Health Systems in the Institute of Health Policy, Management and Evaluation at the Dalla Lana School of Public Health, University of Toronto. She holds a Visiting Scientist appointment at the Institute for the Advanced Study of the Americas, University of Miami and is an Honorary Senior Fellow at the George Institute for Global Health, India.

    She is a global health systems researcher and health economist who leads interdisciplinary research focused on strengthening financial risk protection, supporting effective and equitable priority setting and advancing equity, including gender equity, across global health systems. Her research tackles some of the most pressing issues facing global health and is conducted with a network of collaborators and partnerships across low-, middle- and high-income countries. She has led work for key global health initiatives including the Disease Control Priorities series and the Lancet Taskforce on Non-Communicable Diseases. She co-chairs the Scientific Advisory committee for the Lancet Commission on Gender Based Violence and Maltreatment of Young People and co-leads the Economics working group for this Commission. She is also a Commissioner on the Lancet Commission on Cancer and Health Systems and a Scientific Advisor to the Lancet Commission on Breast Cancer. In 2020 she was recognized on the list of Canadian Women in Global Health for her scholarship and contributions to the field.

Organizing Committee of CGON 2026:

Dr. Danielle Rodin
Prof. Beverley Essue
Arleigh Dean
Luca Bernardini